Julian D Gillmore Selected Research

pyrrolidine

1/2018	Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
1/2018	Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
9/2015	Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
3/2010	Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian D Gillmore Research Topics

Disease

104	Amyloidosis 05/2022 - 06/2002
52	Immunoglobulin Light-chain Amyloidosis 01/2022 - 07/2003
15	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2006
15	Amyloid Plaque 12/2021 - 03/2010
10	Transthyretin-Related Hereditary Amyloidosis 12/2021 - 04/2013
7	Chronic Kidney Failure (Chronic Renal Failure) 05/2022 - 02/2009
7	Polyneuropathies (Polyneuropathy) 01/2022 - 01/2021
6	Proteinuria 01/2019 - 06/2004
5	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 07/2003
4	Inflammation (Inflammations) 09/2017 - 01/2013
4	Renal Insufficiency (Renal Failure) 09/2017 - 06/2004
3	Familial Amyloidosis (Hereditary Amyloidosis) 05/2017 - 06/2014
2	Infections 05/2022 - 11/2015
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2016
2	Disease Progression 09/2018 - 06/2013
2	Schnitzler Syndrome 01/2018 - 02/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2006
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2016 - 06/2014
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 03/2015 - 05/2012
2	Glomerulonephritis 08/2014 - 06/2004
1	Fibrosis (Cirrhosis) 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Atrial Fibrillation 01/2022
1	Amyloid Neuropathies (Amyloid Neuropathy) 06/2021
1	COVID-19 01/2021
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021
1	Adenocarcinoma 11/2020
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Plasma Cell Neoplasms 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 04/2019

Drug/Important Bio-Agent (IBA)

65	Amyloid (Amyloid Fibrils)IBA 03/2022 - 06/2002
45	Prealbumin (Transthyretin)IBA 01/2022 - 06/2002
22	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2003
10	Bortezomib (Velcade)FDA Link 04/2021 - 02/2008
9	AA amyloidosisIBA 01/2021 - 08/2009
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
7	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022 - 07/2003
6	AcidsIBA 01/2022 - 01/2013
6	Pharmaceutical PreparationsIBA 06/2021 - 05/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2007
6	GadoliniumIBA 01/2020 - 02/2014
6	Fibrinogen (Factor I)FDA Link 07/2019 - 06/2002
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2022 - 06/2002
5	AntibodiesIBA 01/2019 - 08/2009
5	Serum Amyloid P-ComponentIBA 01/2018 - 06/2004
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2013
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2011
4	Blood Proteins (Serum Proteins)IBA 12/2021 - 09/2015
4	pyrrolidineIBA 01/2018 - 03/2010
4	Carboxylic AcidsIBA 01/2018 - 03/2010
3	CreatinineIBA 05/2022 - 04/2013
3	patisiranIBA 01/2022 - 01/2021
3	Thalidomide (Thalomid)FDA Link 09/2014 - 01/2007
2	Chemotactic FactorsIBA 11/2020 - 01/2018
2	AntigensIBA 09/2020 - 08/2009
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 09/2014
2	Radioisotopes (Radionuclides)IBA 01/2020 - 11/2019
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2020 - 11/2015
2	Congo RedIBA 01/2019 - 06/2017
2	Immunoglobulin M (IgM)IBA 01/2018 - 11/2008
2	miridesapIBA 01/2018 - 01/2018
2	Complement System Proteins (Complement)IBA 09/2015 - 11/2010
2	GelsolinIBA 12/2014 - 06/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012 - 01/2007
2	Proline (L-Proline)FDA Link 11/2010 - 03/2010
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2009 - 06/2004
2	Melphalan (Alkeran)FDA LinkGeneric 01/2008 - 01/2007
1	DiureticsIBA 01/2022
1	Furosemide (Lasix)FDA LinkGeneric 01/2022
1	Protein Subunits (Protein Subunit)IBA 12/2021
1	Serine Proteases (Serine Protease)IBA 12/2021
1	Fibrinolysin FDA Link 12/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2021
1	TrypsinIBA 11/2021
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 11/2021
1	Apolipoproteins AIBA 11/2021
1	Protein Sorting Signals (Signal Peptide)IBA 11/2021
1	tafamidisIBA 08/2021
1	InotersenIBA 06/2021
1	LigandsIBA 06/2021
1	Antisense OligonucleotidesIBA 06/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	NTLA-2001IBA 01/2021
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2021
1	Vitamin A (Retinol)FDA LinkGeneric 01/2021
1	Monoclonal AntibodiesIBA 09/2020
1	daratumumabIBA 09/2020
1	ixazomibIBA 01/2020
1	carfilzomibIBA 12/2019

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2006
15	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
7	Stem Cell Transplantation 04/2021 - 02/2006
5	Lasers (Laser) 05/2017 - 10/2011
4	Kidney Transplantation 01/2021 - 02/2011
2	Transplantation 05/2022 - 02/2009
2	Liver Transplantation 01/2022 - 05/2010
1	Transcatheter Aortic Valve Replacement 01/2022
1	Hepatectomy 11/2020
1	Organ Transplantation 01/2020